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Cellular metabolism has been shown to regulate differentiation and function of immune cells. Tumor associated immune cells
undergo phenotypic and functional alterations due to the change of cellular metabolism in tumor microenvironments. NKT cells
are good candidates for immunotherapies against tumors and have been used in several clinical trials. However, the influences
of tumor microenvironments on NKT cell functions remain unclear. In our studies, lactic acid in tumor microenvironments
inhibited IFNγ and IL4 productions from NKT cells, and more profound influence on IFNγ was observed. By adjusting the pH of
culture medium we further showed that, dysfunction of NKT cells could simply be induced by low extracellular pH. Moreover,
low extracellular pH inhibited NKT cell functions by inhibiting mammalian target of rapamycin (mTOR) signaling and nuclear
translocation of promyelocytic leukemia zinc-finger (PLZF). Together, our results suggest that tumor acidic microenvironments
could interfere with NKT cell functions through metabolic controls.
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INTRODUCTION
NKT cells are CD1d-restricted T lymphocytes, which pos-
sess semi-invariant TCR, have effector phenotypes and rec-
ognize lipid antigens. Upon activation, NKT cells release
abundant Th1 and Th2 cytokines and regulate functions of
DCs, macrophages, B cells, NK cells and conventional T cells
in a direct or indirect way (Bendelac et al., 2007). As im-
portant immune regulators, NKT cells promote the killing
effects of NK cells and CTLs against tumor cells and also
kill CD1d+ tumor cells directly (Fujii et al., 2013). Thus,
NKT cells are ideal targets for anti-tumor immunotherapies.
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Transferring in vitro expanded NKT cells or αGC-pulsed DCs
showed significant prolonged mean survival time and stabi-
lization of disease (Motohashi et al., 2006; Motohashi et al.,
2009; Motohashi et al., 2011). However, some of those pa-
tients with low IFNγ production showed no clinical effects
(Motohashi et al., 2011). Additionally, decreased NKT cell
numbers and impaired IFNγ productions have been reported
previously in cancer patients and are related to poor clini-
cal outcome (Molling et al., 2007; Motohashi et al., 2011;
Muhammad Ali Tahir et al., 2001). Thus, optimal IFNγ pro-
duction is important for the antitumor effects of NKT cells.
And dysfunction of NKT cells would dampen their antitumor
effects. Antigens and types of antigen-presenting cells are
extrinsic factors modulating the cytokine responses of NKT
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cells (Bai et al., 2009; Bai et al., 2012). However, the fac-
tors causing dysfunction of NKT cells in tumor microenvi-
ronments are still unclear.
Activation of immune cells results in a metabolic repro-
gramming. Upon activation, naïve T cells undergo a switch
from fatty acid oxidation (FAO) and oxidative phosphoryla-
tion to glycolysis in supporting their differentiation into ef-
fector cells such as Th1, Th2 and Th17 (Barbi et al., 2013).
Interestingly, Tregs and memory CD8 T cells utilize oxida-
tive phosphorylation for energy generation. Inhibiting gly-
colysis or enforcing FAO promotes differentiation of memory
CD8 T cells and Tregs (Michalek et al., 2011; Pearce et al.,
2009; Sukumar et al., 2013; van der Windt et al., 2012). And
increased glycolysis has been shown to promote the func-
tions and development of effector CD8 T cells and Th1 cells
(Cham et al., 2008; Chang et al., 2013). Additionally, mam-
malian target of rapamycin (mTOR) signaling, which senses
nutrient availability and controls cellular metabolisms, has
been reported to regulate differentiation of distinct T lineages
(Pollizzi and Powell, 2015). These results demonstrate a link
between cellular metabolism and differentiation and function
of immune cells. Thus, immune cells in solid tumors as well
as in infection sites and inflammation tissues would show dif-
ferent phenotypes and functions from those in normal tissues
due to their distinct metabolic microenvironments. Tumor
microenvironments are gradually formed during the progres-
sion of tumors as indicated by exhaustion of nutrients and ac-
cumulation of lactic acid (Molon et al., 2016; Romero-Garcia
et al., 2016), which have been shown to alter the phenotypes
and functions of tumor resident immune cells through inter-
fering with their cellular metabolism (Kouidhi et al., 2016;
Molon et al., 2016). Nutrient depletion inhibits functions of
CTLs and drives DCs and macrophages to immunosuppres-
sive phenotypes by inhibiting glycolysis (Chang et al., 2015;
Krawczyk et al., 2010). And accumulation of lactic acid has
also been shown to inhibit functions of CTLs and monocytes
(Dietl et al., 2010; Fischer et al., 2007; Peter et al., 2015).
Although the mechanisms by which cellular metabolism reg-
ulates NKT cell functions have not been reported, the dys-
function of NKT cells associated with tumors would hypo-
thetically result from the impaired metabolisms in tumor mi-
croenvironments.
Here, we showed that accumulation of lactic acid in tu-
mor environments caused dysfunction of NKT cells as in-
dicated by dampened IFNγ production and IL4 production
to a less extent. Moreover, we demonstrated that low pH in
culture medium was responsible for the dysfunction of NKT
cells caused by lactic acid accumulation. Moreover, we ob-
served impaired mTOR signaling and nuclear localization of
promyelocytic leukemia zinc-finger (PLZF) in NKT cells in
low pH culture medium. Our results suggest that acidifica-
tion of tumor environments causes dysfunction of NKT cells
by interfering with mTOR signaling.
RESULTS
Lactic acid in tumor microenvironment inhibits NKT cell
functions
Lactate accumulation and acidification of extracellular en-
vironment are hallmarks of solid tumors. Tumor cell lines
BT474, HCC1954, MDAMB231 and B16F10 were cultured
for two days, and the different colours of culture medium in-
dicated different amount of lactic acid productions (Figure
1A). To study the influences of tumor microenvironments on
Figure 1   Lactic acid in tumor microenvironments inhibits functions of NKT cells. A, Productions of lactic acid from indicated tumor cell lines, as shown
by colour of culture medium after two days culture. Data are representative of three independent experiments. B, IL4 and IFNγ productions from NKT cells
activated by RBL.CD1d cells and αGC in the absence or presence of indicated tumor cells (2×105 cells). Data are pooled from two independent experiments. C,
Lactic acid productions from B16F10 cells and BT474 cells at indicated numbers after 24 h culture. The data are pooled from three independent experiments.
D, IL4 and IFNγ productions from NKT cells activated by RBL.CD1d cells and αGC in the absence or presence of lactic acid at indicated concentrations. The
data are pooled from two independent experiments. Error bars are mean±SE. **, P<0.01; ***, P<0.001; ****, P<0.0001.
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NKT cell functions, NKT cells plus RBL.CD1d cells in up-
per chamber were co-cultured with tumor cells in lower plate
in the presence of αGC in transwell systems. Two tumor cell
lines with different lactic acid productions were chosen based
on the colour of culture medium. B16F10 cells releasing
high level of lactic acid significantly inhibited IFNγ and IL4
productions from NKT cells in transwell co-culture system.
Whereas BT474, which produced less amount of lactic acid,
showed no influence on cytokine productions fromNKT cells
(Figure 1B and C). To further investigate whether accumula-
tion of lactic acid alone would result in the dysfunction of
NKT cells, NKT cells and RBL.CD1d cells were co-cultured
in the presence of αGC with or without lactic acid treatment.
Consistently, lactic acid inhibited IFNγ and IL4 productions
in a dose dependent way, and more profound influence was
observed on IFNγ than on IL4 (Figure 1D).
Extracellular acidification inhibits NKT cell functions in-
dependent of TCR signaling
Lactic acid accumulation causes acidification of extracellular
environment. Thus, the dysfunction of NKT cells induced
by lactic acid could be a result of dropped extracellular pH.
To test this possibility, we adjusted medium pH back to 7.3
in lactic acid treated groups by adding NaOH. Interestingly,
NaOH was capable to restore the IFNγ and IL4 productions
(Figure 2A). Next, we changed the pH of culture medium to
Figure 2   Low pH inhibits functions of NKT cells independent of TCR signaling. A, Cytokine productions from NKT cells activated by RBL.CD1d cells and
αGC in the absence or presence of lactic acid (20 mmol L−1) and with or without pH adjusted back to 7.3 by adding NaOH. The data are representative of two
independent experiments. B, Cytokine productions from NKT cells activated by RBL.CD1d cells and αGC at pH 7.3 or pH 6.8. The data are pooled from two
independent experiments. C, CD1d-αGC on cell surface was detected by L363. Mean fluorescence intensity of L363 was shown. The data are representative
of two independent experiments. D, Cytokine productions from NKT cells activated by plate-coated anti-CD3 and anti-CD28 at pH 7.3 or pH 6.8. The data are
representative of three independent experiments. E, mRNA levels of cytokines in NKT cells activated at pH 7.3 or pH 6.8 by RBL.CD1d cells pulsed with αGC.
The data are representative of three independent experiments. F–G, Cytokine productions from NKT cells activated by PMA (50 ng mL−1) and ionomycin (1
μmol L−1) in pH 7.3 or pH 6.8 culture medium (F), or in the absence or presence of lactic acid (G). The data are representative of two independent experiments.
Error bars are mean±SE. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.
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6.8 by adding HCl without lactic acid, mimicking the pH in
tumors in vivo. NKT cells and RBL.CD1d cells were co-cul-
tured in presence of αGC in normal medium or in pH 6.8
medium. Consistently, extracellular acidification inhibited
IFNγ and IL4 productions from NKT cells (Figure 2B). And
more profound influence was observed on IFNγ.These results
suggested that change of pH but not accumulation of lactate
caused dysfunction of NKT cells. To exclude the possibility
that dysfunction of NKT cells was due to the impaired anti-
gen presentation, we measured the level of CD1d-αGC com-
plex on RBL.CD1d cell surface with antibody L363. Simi-
lar amount of surface CD1d-αGC complex was detected in
cells culturing at pH 7.3 and pH 6.8 (Figure 2C). And in anti-
gen presenting cell-free system, NKT cells were stimulated
by plate-coated anti-CD3 and anti-CD28 in pH 7.3 or pH
6.8 medium, and down-regulation of IFNγ production from
NKT cells was also observed at pH 6.8 (Figure 2D).Whereas
no effect on IL4 production was observed. Thus, extracellu-
lar acidification inhibited NKT cell functions independent of
influence on antigen presentation. Additionally, we showed
that low pH inhibited cytokines at the transcriptional level
(Figure 2E). To further investigate whether low pH influenced
TCR signaling, we stimulated NKT cells with PMA plus ion-
omycin bypassing the TCR signaling in pH 6.8 medium or in
the presence of lactic acid. And under both conditions, we
observed dysfunction of NKT cells (Figure 2F and G). Thus,
extracellular acidification inhibited NKT cell cytokine pro-
ductions by modulating pathways downstream TCR signal-
ing.
Extracellular acidification does not change cell viability
To investigate whether the dysfunction of NKT cells was due
to increased cell death in acidic environment, we stainedNKT
cells with propidium iodide (PI) after 24 h stimulation in nor-
mal medium or in pH 6.8 medium. Decreased dead cells were
observed at pH 6.8, excluding the possibility that increased
mortality caused dysfunction of NKT cells (Figure 3).
Figure 3   Low pH does not influence the viability of NKT cells. Percent-
ages of PI+ NKT cells after activation with RBL.CD1d cells and αGC in pH
7.3 or pH 6.8 medium for 24 h. The data are pooled from two independent
experiments. Error bars are mean±SE. *, P<0.05; **, P<0.01.
Extracellular acidification interfered with mTOR signal-
ing in NKT cells upon activation
mTOR signaling has been critically linked to cellular metabo-
lisms and immunity by previous studies (Powell et al., 2012;
Vitiello et al., 2015; Weichhart et al., 2015). Activation of
mTOR signaling was observed in NKT cells upon activation.
However, impaired mTOR signaling was detected in NKT
cells activated in pH 6.8 medium or in the presence of lac-
tic acid, as indicated by less amounts of p-S6 and p-4E-BP1
(Figure 4A and B). And pH 6.8 medium dampened mTOR
signaling to a lesser extent than 20 mmol L−1 lactic acid did,
which was in consistence with their influences on cytokine
productions. It has been reported that mTOR signaling regu-
lates development and cytokine productions of NKT cells via
controlling nuclear translocation of transcription factor PLZF
(Shin et al., 2014). PLZF is a signature transcription fac-
tor for NKT cells, which controls development and effector
programs of NKT cells (Savage et al., 2008). Nuclear local-
ization is important for the functions of PLZF. In mTORC1
signaling deficient mice, diminished nuclear localization of
PLZF and diminished cytokine productions were observed in
NKT cells (Shin et al., 2014). In consistence with previous
studies, we also detected less nuclear translocation of PLZF
in NKT cells activated in the presence of lactic acid (Figure
4C). Thus, our results suggested that acidic tumor microen-
vironments caused dysfunction of NKT cells by interfering
with mTOR signaling and PLZF nuclear translocation.
DISCUSSION
Immune evasion of tumor is the major reason for tumor
progression. The underlying mechanisms include defective
antigen presentations, impaired expression of costimulatory
molecules, increased inhibitory mediators and accumulation
of immunosuppressive cells (Liu and Cao, 2015; Mapara
and Sykes, 2004). Moreover, warburg effect of tumor cells
results in special microenvironments especially in solid
tumors, which are characterized by nutrient depletion and
low pH (Vander Heiden et al., 2009). Metabolic regulations
on differentiation and function of immune cells have been
reported recently. Similar as tumor cells, M1 macrophages,
DCs, Th1 cells and CTLs utilize glycolysis for energy
supply. Whereas the pro-tumor immune cells, such as M2
macrophages, regulatory DCs and Tregs, undergo oxidative
phosphorylation (Biswas, 2015; Wang et al., 2014). And
accumulation of lactic acid would influence cell functions
by interfering with glycolysis. Together, competition for
nutrients and accumulation of lactic acid would inhibit the
development and functions of anti-tumor cells but favor
the pro-tumor cells (Chang et al., 2015; Dietl et al., 2010;
Fischer et al., 2007). Thus, tumor microenvironments could
be  another  explanation  for  the failed immune surveillance
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Figure 4   Low pH impairs mTOR signaling and translocation of PLZF in activated NKT cells. A and B, Phosphorylation of S6 (A) and 4E-BP1 (B) in NKT
cells activated by plate-coated anti-CD3 and anti-CD28 for 24 h in pH 7.3 or pH 6.8 medium or in the presence of 20mmol L−1 lactic acid. Data are representative
of two independent experiments. C, Localization of PLZF in NKT cells inactivated or activated by plate-coated anti-CD3 and anti-CD28 in the presence or
absence of lactic acid (20 mmol L−1). Red, PLZF; blue, 4′,6-diamidino-2-phenylindole, DAPI. Scale bars, 5 μm. Error bars are mean±SE. **, P<0.01; ****,
P<0.0001.
against tumors.
NKT cells, as the bridge of innate and adaptive immunity,
serve as the first line of body defense. In addition to killing
the CD1d expressing tumor cells directly, activation of NKT
cells has been shown to promote the functions of NK cells
and CTLs (Fujii et al., 2013). Due to these advantages, NKT
cells are good candidates for immunotherapies against tu-
mors. However, our results indicate a significant influence of
tumor microenvironments on NKT cell functions. Dysfunc-
tion of NKT cells, especially diminished IFNγ production,
was induced by low pH in tumors (Figure 2). These results
could explain the abnormal functions of NKT cells associated
with tumors and the failed NKT cell-based immunotherapies.
Additionally, we demonstrated that low pH impaired activa-
tion of mTOR signaling and downstream PLZF transloca-
tion (Figure 3). mTOR signaling has been previously shown
to regulate nuclear localization of PLZF, which is important
for NKT cell effector functions (Shin et al., 2014). More-
over, mTOR signaling and lactic acid have been reported to
regulate glycolysis (Dietl et al., 2010; Powell et al., 2012).
Thus, our results do not exclude the possibility that other
factors influencing cellular metabolism, such as glycolysis,
would also regulate NKT cell functions in tumor microenvi-
ronments. The mechanisms by which mTOR signaling regu-
lates PLZF localization remain unclear. It has been reported
that mTORC1 but not mTORC2 regulates nuclear localiza-
tion of PLZF (Prevot et al., 2015).
It is not clear whether activating NKT cells and interfering
with the production of lactic acid from tumor cells would re-
sult in a synergic effect. However, recent studies on anti-PD1
treatment demonstrate a very promising future for therapies
targeting on both tumor immunity and tumor microenviron-
ments. In addition to the blockade of inhibitory receptors,
anti-PD1 treatment inhibits tumor growth by directly regulat-
ing tumor cell metabolism and reducing the glucose exhaus-
tion in tumor microenvironments, which promotes CTL func-
tions on the other side (Chang et al., 2015). Thus, except for
the immune cells and checkpoint molecules, the tumor mi-
croenvironments would also be targets of immunotherapies.
Normal tissue microenvironments are required to maintain
the function of anti-tumor cells and also may be important
for the migration of anti-tumor cells. Combination therapies
are required in the future.
MATERIALS AND METHODS
Mice
Vα14 Tg.cxcr6gfp/+ mice were previously described and pro-
vided by Dr. Albert Bendelac (Bai et al., 2012; Scanlon et al.,
2011). Mice were housed under specific pathogen-free con-
ditions. All animal procedures were approved by the Univer-
sity of Science and Technology of China (USTC) Institutional
Animal Care and Use Committee. And all experiments were
performed in accordance with the approved guidelines.
Cell culturing
The B16F10 cells, MDAMB231 cells, BT474 cells and
HCC1954 cells were cultured in DMEM medium (Gibco,
USA) supplemented with 10% FBS. RBL.CD1d cells and
NKT cells were cultured in RPMI-1640 medium (Gibco)
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supplemented with 10% FBS and 50 μmol L−1 βME.
Cell enrichment
Vα14 Tg.cxcr6gfp/+ mice were sacrificed and spleens were
minced and passed through 70 μm meshes. Cells were
blocked with anti-CD16/32 for 15 min, and stained with
anti-CD4-APC for 30 min on ice. NKT cells were enriched
with anti-APC microbeads (Miltenyi Biotec, Germany). In
some experiments, purified NKT cells were obtained by sort-
ing as CD4+ and GFPhi cells from livers of Vα14 Tg.cxcr6gfp/+
mice.
Activation of NKT cells
For NKT cell activation, 3×104 RBL.CD1d cells and 4×104
enriched NKT cells were co-cultured in the presence of
αGC (1 μg mL−1) or DMSO as control for 24 h. Cytokines
in supernatant were detected by CBA kit (BD, USA). To
study the NKT cell functions in tumor microenvironments
in vitro, indicated tumor cells (2×105 cells per well) were
seeded in lower plate and enriched NKT cells were co-cul-
tured with RBL.CD1d cells in upper chamber (Millipore,
USA) in the presence of αGC (1 μg mL−1). In cell-free
stimulation assays, sorted NKT cells (2×105 per well) were
stimulated with plate-coated anti-CD3 (10 μg mL−1) and
anti-CD28 (10 μg mL−1) for 24 h. Alternatively, purified
NKT cells were stimulated with 1 μmol L−1 ionomycin and
50 ng mL−1 PMA for 24 h.
Flow cytometry
Cells were suspended in PBS buffer containing 1% BSA, and
blocked with anti-CD16/32 for 15 min on ice, then stained
with monoclonal antibody for 30 min on ice. Monoclonal
antibodies were listed here: purified anti-CD16/32 (93),
anti-CD4 (GK1.5), anti-TCRβ (H57-597). All antibodies
were purchased from BioLegend (USA). CD1d-PBS57
tetramer is provided by National Institute of Health (NIH)
Tetramer Core Facility. To detect intracellular phospho-S6
(pS6), or phospho-4E-BP1 (p4E-BP1), sorted NKT cells
were fixed with 2% PFA and permeabilized with 90%
pre-cooling methanol. Cells were stained with rabbit
anti-pS6 (Ser235/236, Cell Signaling Technology, USA) or
rabbit anti-p4E-BP1 (T37/46, Cell Signaling Technology)
antibodies. For antigen presentation assays, RBL.CD1d cells
were cultured in the presence of αGC (1 μg mL−1) at different
pH for 24 h. Cells were digested by trypsin and washed with
PBS buffer. After blocking, RBL.CD1d cells were stained
with antibody against CD1d-αGC complex (L363). Cells
were acquired by FACSVerse (BD). And data was analyzed
with FlowJo 7.6 software.
Confocal
Sorted NKT cells were stimulated by plate-coated anti-CD3
(10 μg mL−1) and anti-CD28 (10 μg mL−1) for 12–14 h in
culture dishes. Cells were fixed with 4% PFA for 15 min, and
then permeabilized with 0.1% Triton X-100 for 30 min. Cells
were washed and stained with PE-conjugated anti-PLZF
(4 μg mL−1) and DAPI (1.5 μg mL−1) for 4 h on ice. Images
were collected with an LSM 710 (Zeiss, Germany) inverted
microscope. Data was analyzed with ImageJ.
Statistical analysis
Error bars represent SE. The statistical significance of differ-
ences between two groups was determined by the unpaired
two-tailed student’s t test.
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